000			01924 a2200589 4500
005			20250514230221.0
264		0	_c20060425
008			200604s 0 0 eng d
022			_a1538-4047
024	7		_a10.4161/cbt.4.6.1731 _2doi
040			_aNLM _beng _cNLM
100	1		_aSparreboom, Alex
245	0	0	_aEffect of ABCG2 genotype on the oral bioavailability of topotecan. _h[electronic resource]
260			_bCancer biology & therapy _cJun 2005
300			_a650-8 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aATP Binding Cassette Transporter, Subfamily G, Member 2
650	0	4	_aATP-Binding Cassette Transporters _xgenetics
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAmino Acid Substitution
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aBiological Availability
650	0	4	_aCarcinoma, Small Cell _xgenetics
650	0	4	_aDNA, Neoplasm _xgenetics
650	0	4	_aFemale
650	0	4	_aGene Frequency
650	0	4	_aGenotype
650	0	4	_aHeterozygote
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xgenetics
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Proteins _xgenetics
650	0	4	_aOvarian Neoplasms _xgenetics
650	0	4	_aPharmacogenetics
650	0	4	_aPilot Projects
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aProspective Studies
650	0	4	_aTopotecan _xadministration & dosage
650	0	4	_aTumor Cells, Cultured
700	1		_aLoos, Walter J
700	1		_aBurger, Herman
700	1		_aSissung, Tristan M
700	1		_aVerweij, Jaap
700	1		_aFigg, William D
700	1		_aNooter, Kees
700	1		_aGelderblom, Hans
773	0		_tCancer biology & therapy _gvol. 4 _gno. 6 _gp. 650-8
856	4	0	_uhttps://doi.org/10.4161/cbt.4.6.1731 _zAvailable from publisher's website
999			_c15570724 _d15570724